Holen Sie sich die Stockscreener-App
5.15
3.56%
-0.19
Vorhandelsmarkt:
5.14
-0.01
-0.19%
Schlusskurs vom Vortag:
$5.34
Offen:
$5.2
24-Stunden-Volumen:
48,347
Relative Volume:
0.46
Marktkapitalisierung:
$2.42M
Einnahmen:
$9.00M
Nettoeinkommen (Verlust:
$-7.21M
KGV:
-9.3636
EPS:
-0.55
Netto-Cashflow:
$-7.59M
1W Leistung:
+11.23%
1M Leistung:
+10.77%
6M Leistung:
-96.53%
1J Leistung:
-98.44%
1-Tages-Spanne:
$5.015
$5.28
1-Wochen-Bereich:
$4.56
$5.6499
52-Wochen-Spanne:
$4.365
$2,655.00
Applied Dna Sciences Inc Stock (APDN) Company Profile
Firmenname
Applied Dna Sciences Inc
Sektor
Branche
Telefon
631-240-8800
Adresse
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Vergleichen Sie APDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
5.15 | 2.42M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
434.86 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
204.85 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
533.37 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
123.28 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
162.80 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-02-12 | Eingeleitet | ROTH Capital | Buy |
| 2021-01-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-20 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-14 | Bestätigt | Maxim Group | Buy |
| 2016-05-13 | Bestätigt | Maxim Group | Buy |
| 2015-10-08 | Bestätigt | Maxim Group | Buy |
| 2015-05-26 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2015-02-10 | Bestätigt | Maxim Group | Buy |
| 2015-01-13 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Applied Dna Sciences Inc Aktie (APDN) Neueste Nachrichten
Applied DNA Sciences Regains Nasdaq Compliance - The Globe and Mail
Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements - Great Falls Tribune
Applied DNA Sciences regains Nasdaq compliance with $1 minimum bid By Investing.com - Investing.com Nigeria
Applied DNA Sciences regains Nasdaq compliance, scheduled hearing cancelled - Investing.com
Applied DNA Sciences regains Nasdaq compliance with $1 minimum bid - Investing.com
Applied DNA Just Cleared Critical $1 Nasdaq Requirement: Delisting Risk Eliminated - Stock Titan
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx - Marco Eagle
Applied DNA Sciences Announces Strategic Restructuring - TipRanks
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward - The Tennessean
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward | APDN Stock News - GuruFocus
Applied DNA Sciences names Judy Murrah as new chairperson and CEO - Investing.com India
Applied DNA Sciences names Judy Murrah as new chairperson and CEO By Investing.com - Investing.com South Africa
APDN Leadership Transition: Judy Murrah Appointed CEO | APDN Sto - GuruFocus
Applied DNA Sciences Appoints Harvard MBA Veteran Judy Murrah as CEO, Founder Retires After Two Decades - Stock Titan
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August - Knoxville News Sentinel
Applied DNA Sciences (APDN) to Restart Quarterly Investor Calls | APDN Stock News - GuruFocus
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August | APDN Stock News - GuruFocus
Applied DNA Sciences Returns to Regular Earnings Updates: What Investors Should Know About New Schedule - Stock Titan
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - Knoxville News Sentinel
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q3 2024 Earnings Call Transcript - MSN
Applied DNA Sciences fails to secure shareholder vote - MSN
applied dna sciences faces nasdaq delisting due to bid price rule - Investing.com
Applied DNA Sciences Faces Nasdaq Delisting Hearing - TipRanks
Top Premarket Gainers - MarketScreener
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 - Livingston Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - Knoxville News Sentinel
Upcoming Stock Splits This Week (June 2 to June 6) – Stay Invested - The Globe and Mail
Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World
APDN stock plunges to 52-week low of $0.32 amid market challenges By Investing.com - Investing.com South Africa
APDN Trading Halted as Market Awaits Significant Announcement | APDN Stock News - GuruFocus
APDN stock plunges to 52-week low of $0.32 amid market challenges - Investing.com Nigeria
Finanzdaten der Applied Dna Sciences Inc-Aktie (APDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):